23andMe Reportedly Considers Selling Lemonaid Telehealth Unit
23andMe is reportedly considering the sale of Lemonaid Health, its telehealth operation.
The consumer genetic testing kit company acquired Lemonaid in 2021 for $400 million and is now weighing a sale,...